-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
What is the current situation of the development of biomedical technology innovation in China? At present, China's basic scientific research is in an important transformation from tracking catch-up to parallel development.
But there are also some problems, such as the lack of original achievements to open up the frontier, the lack of leading talents in science and technology, the uneven layout of disciplines, the atmosphere of innovation culture is not strong, basic research to support and lead the development of the industry mechanism is not mature enough.
currently engaged in scientific research has been very large, in many technical fields have made very significant progress.
the conversion rate of scientific and technological achievements in China is only 10%.
is still a long way from developed countries; the world's scientific research landscape is changing significantly, with total global spending growing at an average annual rate of 6.7 per cent between 2001 and 2011.
2011, global spending on R and D exceeded $1435 billion (1051 billion in 2006 and 753 billion in 2001).
the top seven countries in 2011 accounted for about three-quarters of the world's total, with the top three countries, the United States, China and Japan, accounting for more than 50 percent of the world's total.
U.S. remains the largest implementer of the R and D, spending $429 billion in 2011, almost a third of the world's total, but its share fell to 30 percent from 37 percent in 2001.
The innovative achievements of scientists in colleges and universities can not find the direction, the way out, pharmaceutical entrepreneurs can not find a good innovation project, the national repetitive research, repetitive projects increased, in the biopharmaceutical industrialization of the industrial chain formed a variety of information islands;
learn more about biomedical technology, you can follow biomedical information reading: .
.